- No decision has been made on the licence application
- A draft risk assessment has been prepared which concludes that the trial poses negligible risks to people and the environment
- Comment is now invited on the draft risk assessment
- If the trial is approved, the vaccine would be administered as a drink to volunteers by qualified health professionals in clinical facilities.